ND-7

N/A

Report date: 2025/01/26 18:20:04

Base Information

Drug NameND-7
Drug Alias NameGCase stimulator (New York University Grossman School of Medicine/Cincinnati Childrens Hospital Medical Center)recombinant progranulin (New York University Grossman School of Medicine/Cincinnati Children's Hospital Medical Center)glucocerebrosidase stimulator (New York University Grossman School of Medicine/Cincinnati Children's Hospital Medical Center)ND-7
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucosylceramidase stimulants
TargetsGlucosylceramidase
Therapy Area/IndicationsGaucher Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNew York University School Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesNew York University School Of MedicineCincinnati Children'S Hospital Medical Center
Inactive CompaniesN/A
Active IndicationsGaucher Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A